Please login to the form below

Not currently logged in
Email:
Password:

AZD0914

This page shows the latest AZD0914 news and features for those working in and with pharma, biotech and healthcare.

Cubist antibiotic to get priority review in US

Cubist antibiotic to get priority review in US

It is the second boost for new antibiotics in the US this month after the FDA's decision to grant fast track status to AstraZeneca's AZD0914 for the sexually transmitted

Latest news

  • FDA fast-tracks new AstraZeneca antibiotic FDA fast-tracks new AstraZeneca antibiotic

    FDA fast-tracks new AstraZeneca antibiotic. Speeds up review period for AZD0914 in gonorrhoea. ... AZD0914 has shown promise as a treatment for the sexually transmitted infection (STI) uncomplicated gonorrhoea, which, like other infectious diseases, is

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CACTUS

Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics